A Biopharmaceutical Company

News and Events

February 27, 2018

Abexxa Biologics – Re-Imagining Cancer Immunotherapy for the many.

Jon Weidanz, CSO, talks about re-imaging cancer immunotherapy and the essential ingredients for successful partnerships

May 22, 2017

Abexxa Biologics has been selected as one of the 40 Best University Startups 2017

AbeXXa Biologics, a faculty startup at The University of Texas at Arlington, was named one of the 40 “Best University Startups 2017” by the National Council of Entrepreneurial Tech Transfer, a Washington-based association of startup officers from the top research universities in the United States.

December 11, 2017

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

AbeXXa is looking to identify a new series of selective molecular targets for cancer from the many thousands of proteins found on the interior of a tumor cell.

February 26, 2017

Star-Telegram UTA raises cancer research profile with $6 million in grants

“It drives the success of the local economies in those areas,” said Weidanz, whose research focus is on an emerging field of therapies and treatments aimed at using a patient’s immune system to fight cancer. UTA recruited him partly for his experience starting research companies.

December 14, 2016

Abexxa Biologics won the Annual Innovation prize from #BIAcademy for their immunotherapy research & earned a Golden Ticket to Lab Central.

Abexxa Biologics wins space in lab central in Cambridge Massachusetts.

Abexxa will focus on exploiting its novel targets for the development of next generation anti-cancer agents.

© Copyright Abexxa Biologics, Inc. All Rights Reserved.

  • Home
  • About Us
  • News and Events
  • Contact Us